Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312379586> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4312379586 abstract "Background: Type 2 diabetic (T2D) patients are 40% more likely to develop cardiovascular diseases compared to healthy individuals. Previously, we have shown that circulating gut peptides such as peptidoglycan (PGN) aggravate myocardial fibrosis through DNA hypomethylation-induced activation of TLR2; however, the underlying molecular mechanisms responsible remain elusive. Hypothesis: Gut microbial antigens activate MyD88/IRAK4/NF-κB signaling through TLR2 in cardiac tissue, resulting in myocardial fibrosis and cardiac dysfunction in T2D. Methods: Gut barrier integrity, cardiac inflammation, and DNA hypomethylation (5hmC) were measured in cardiac tissue via IHC, qPCR, ELISA, and western blot analysis in db/db mice, a murine model of T2D with 4 months of diabetes and age-matched controls. PGN-treated cardiac fibroblasts were analyzed via in-vitro studies with and without IRAK4 and NF-κB inhibitors. Results: db/db mice exhibited cardiac dysfunction and myocardial fibrosis as measured by reduced LVEF and LVFS with increased LV mass and collagen synthesis. These mice also exhibited higher gut permeability as observed by reduced tight junctional proteins (ZO-1, p120-catenin, and VE-cadherin, YAP, PV1) and increased levels of plasma FABP-2. The levels of PGN were higher in plasma (p<0.003) and cardiac tissue (p<0.001) of db/db mice. The expression of TLR2 (p<0.003) and pro-inflammatory cytokines IL-1β (p<0.008) and TNF-α (p<0.0004) were significantly up-regulated in diabetic hearts compared to WT. Expression of 5hmC was significantly higher (p<0.001) in the hearts of diabetic mice. Increased expression of 5hmC, ten-eleven translocation 1-3 (TET-1, 2, 3), IL-1β, IL-6, and TNF-α were also observed in PGN-treated cardiac fibroblasts. IRAK4 (PF-06650883; 10μM) and NF-κB (CAPE; 50 μM) inhibition reduced the PGN-mediated fibroblast activation, resulting in reduced inflammation. Conclusions: Increased circulating gut microbial antigens by induction of systemic and cardiac inflammatory pathways result in damage to the myocardium of db/db mice. Therapies designed to restore the gut barrier and reduce TLR2 activation may potentially minimize the risk of diabetes-induced cardiovascular complications." @default.
- W4312379586 created "2023-01-04" @default.
- W4312379586 creator A5010909877 @default.
- W4312379586 creator A5032227273 @default.
- W4312379586 creator A5042170792 @default.
- W4312379586 creator A5044981782 @default.
- W4312379586 creator A5057917635 @default.
- W4312379586 creator A5058833186 @default.
- W4312379586 creator A5083537513 @default.
- W4312379586 date "2022-08-05" @default.
- W4312379586 modified "2023-10-15" @default.
- W4312379586 title "Abstract P2054: Epigenetic Regulation Of TLR2 By Gut Microbial Antigens Aggravates Myocardial Fibrosis Through Activating Myd88/IRAK4/NF-kB Signaling In Type 2 Diabetes" @default.
- W4312379586 doi "https://doi.org/10.1161/res.131.suppl_1.p2054" @default.
- W4312379586 hasPublicationYear "2022" @default.
- W4312379586 type Work @default.
- W4312379586 citedByCount "0" @default.
- W4312379586 crossrefType "journal-article" @default.
- W4312379586 hasAuthorship W4312379586A5010909877 @default.
- W4312379586 hasAuthorship W4312379586A5032227273 @default.
- W4312379586 hasAuthorship W4312379586A5042170792 @default.
- W4312379586 hasAuthorship W4312379586A5044981782 @default.
- W4312379586 hasAuthorship W4312379586A5057917635 @default.
- W4312379586 hasAuthorship W4312379586A5058833186 @default.
- W4312379586 hasAuthorship W4312379586A5083537513 @default.
- W4312379586 hasConcept C104317684 @default.
- W4312379586 hasConcept C126322002 @default.
- W4312379586 hasConcept C134018914 @default.
- W4312379586 hasConcept C2776070231 @default.
- W4312379586 hasConcept C2776415932 @default.
- W4312379586 hasConcept C2776914184 @default.
- W4312379586 hasConcept C2777420927 @default.
- W4312379586 hasConcept C2780559512 @default.
- W4312379586 hasConcept C2781236682 @default.
- W4312379586 hasConcept C3018763269 @default.
- W4312379586 hasConcept C55493867 @default.
- W4312379586 hasConcept C71924100 @default.
- W4312379586 hasConcept C86803240 @default.
- W4312379586 hasConceptScore W4312379586C104317684 @default.
- W4312379586 hasConceptScore W4312379586C126322002 @default.
- W4312379586 hasConceptScore W4312379586C134018914 @default.
- W4312379586 hasConceptScore W4312379586C2776070231 @default.
- W4312379586 hasConceptScore W4312379586C2776415932 @default.
- W4312379586 hasConceptScore W4312379586C2776914184 @default.
- W4312379586 hasConceptScore W4312379586C2777420927 @default.
- W4312379586 hasConceptScore W4312379586C2780559512 @default.
- W4312379586 hasConceptScore W4312379586C2781236682 @default.
- W4312379586 hasConceptScore W4312379586C3018763269 @default.
- W4312379586 hasConceptScore W4312379586C55493867 @default.
- W4312379586 hasConceptScore W4312379586C71924100 @default.
- W4312379586 hasConceptScore W4312379586C86803240 @default.
- W4312379586 hasIssue "Suppl_1" @default.
- W4312379586 hasLocation W43123795861 @default.
- W4312379586 hasOpenAccess W4312379586 @default.
- W4312379586 hasPrimaryLocation W43123795861 @default.
- W4312379586 hasRelatedWork W2360754837 @default.
- W4312379586 hasRelatedWork W2735815044 @default.
- W4312379586 hasRelatedWork W2896102150 @default.
- W4312379586 hasRelatedWork W2900276435 @default.
- W4312379586 hasRelatedWork W2912905717 @default.
- W4312379586 hasRelatedWork W2983478349 @default.
- W4312379586 hasRelatedWork W3153505484 @default.
- W4312379586 hasRelatedWork W3198414371 @default.
- W4312379586 hasRelatedWork W4214709313 @default.
- W4312379586 hasRelatedWork W4312379586 @default.
- W4312379586 hasVolume "131" @default.
- W4312379586 isParatext "false" @default.
- W4312379586 isRetracted "false" @default.
- W4312379586 workType "article" @default.